ANDA 63080, held by Hospira. Tobramycin Sulfate.
As of Nov 16, 2026, ANDA 63080 (Tobramycin Sulfate), held by Hospira, was first approved by FDA on Apr 30, 1991, with 8 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 30, 1991 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Tobramycin SulfateEQ 10MG BASE/ML ยท injectable;injection | Tobramycin Sulfate | Discontinued |
| Apr 9, 2001 | Supplement 10Manufacturing | Approved | None posted |
| Feb 16, 1999 | Supplement 9Manufacturing | Approved | None posted |
| Nov 23, 1998 | Supplement 7Manufacturing | Approved | None posted |
| Nov 23, 1998 | Supplement 8Manufacturing | Approved | None posted |
| May 10, 1995 | Supplement 5Manufacturing | Approved | None posted |
| Jun 28, 1994 | Supplement 4Labeling | Approved | None posted |
| May 20, 1993 | Supplement 1Manufacturing | Approved | None posted |
| Oct 30, 1992 | Supplement 2Manufacturing | Approved | None posted |
| Apr 30, 1991 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters